Category Archives: Mesenchymal Stem Cells

Treatment for Degenerative, Bulging and Herniated Discs Minimally Invasive Stem Cell Therapy Treatment for Bulging and Herniated Discs in Thailand http://stemcellthailand.org/services-list/stem-cell-treatment-degenerative-disc-disease-back-surgery-al... By: Regeneration Center of Thailand … Continue reading →

Heba Degheidy, M.D., Ph.D., a visiting research associate at FDA, stores stem cell samples for analysis in an FDA laboratory on the National Institutes of Health (NIH) campus in Bethesda, Md. Steven R. Bauer, Ph.D., chief of the Cellular and Tissue Therapy Branch in FDAs Office of Cellular Tissue and Gene Therapies (standing), visits his team of scientists in their lab. For more photos of FDA's stem cell research team at work go to Flickr. Get Consumer Updates by E-mail Consumer Updates RSS Feed Print & Share (PDF 308 K) On this page: Scientists sporting white coats and safety gloves are working in a bright Food and Drug Administration (FDA) lab on an incredible project. They are part of FDAs MSC Consortium, a large team of FDA scientists studying adult mesenchymal stem cells (MSCs)cells that could eventually be used to repair, replace, restore or regenerate cells in the body, including those needed for heart and bone repair. The scientistsinvestigational work is unprecedented: Seven labs at FDA's Center for Biologics Evaluation and Research formed the consortium to fill in gaps in knowledge about how stem cells function. Follow this link: Adult Stem Cell Research Shows Promise … Continue reading →

Stem Cells and Multiple Sclerosis Dr Colin Andrews speaks about the optimistic results of treating MS (multiple sclerosis) with stem cell therapy and the ethical limitations within Australia. By: Norwood Day Surgery … Continue reading →

PUBLIC RELEASE DATE: 23-Apr-2014 Contact: Robert Miranda cogcomm@aol.com Cell Transplantation Center of Excellence for Aging and Brain Repair Putnam Valley, NY. (Apr. 23, 2014) People who have had a stroke, often suffer motor deficits with little potential to restore neurological function. However, a study conducted in Taiwan, that will be published in a future issue of Cell Transplantation, but is currently freely available on-line as an unedited early e-pub at: http://www.ingentaconnect.com/content/cog/ct/pre-prints/content-ct1168Chen, has found that when one group of stroke victims had their own peripheral blood stem cells (PBSCs) injected directly into the brain and a similar group did not, those who received the PBSCs experienced some "improvement in stroke scales and functional outcome." Those in the PBSC-injected group also received injections of the growth factor granulocyte-colony stimulating factor (G-CSF), known to be potentially neuroprotective. "In this phase 2 study, we provide the first evidence that intracerebral injection of autologous (self-donated) PBSCs can improve motor function in those who have suffered a stroke and have motor deficits as a result," said study corresponding Dr. Woei-Cheng Shyu of the Center for Neuropsychiatry, Graduate Institute of Immunology and Translational Medicine Research Center, China Medical University in Taiwan. "Our study demonstrated that this therapeutic … Continue reading →

Thousand Oaks, CA (PRWEB) April 23, 2014 The Irvine Stem Cell Treatment Center, PC, located in Irvine, California, announces a free public seminar on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief. The seminar will be held on Tuesday, April 29th at 4:00 p.m. and 7:00 p.m. at the Thousand Oaks Library, 1401 E. Janss Road, Thousand Oaks, CA. At the Irvine Stem Cell Treatment Center, utilizing investigational protocols, adult adipose derived stem cells (ADSCs) can be deployed to improve patients quality of life with a number of degenerative conditions and diseases. ADSCs are taken from the patients own adipose (fat) tissue (also called stromal vascular fraction (SVF)). Adipose tissue is exceptionally abundant in ADSCs. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctors office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity. ADSCs are the body's natural healing cells - they are recruited by chemical signals emitted by … Continue reading →

Deerfield Beach, Florida (PRWEB) April 23, 2014 The Miami Stem Cell Treatment Center, PC, located in Miami, Ft. Lauderdale, and Boca Raton, Florida, announces their invite to speak at the Forum at Deer Creek in Deerfield, Florida on the use of stem cells for various degenerative and inflammatory conditions. This will be provided by Dr. Nia Smyrniotis, Medical Director. This seminar will be held on April 28 at 2:30 pm at the Forum at Deer Creek, 3001 Deer Creek Country Club Blvd., Deerfield Beach, FL 33442. At the Miami Stem Cell Treatment Center, utilizing investigational protocols, adult adipose derived stem cells (ADSCs) can be deployed to improve patients quality of life with a number of degenerative conditions and diseases. ADSCs are taken from the patients own adipose (fat) tissue (also called stromal vascular fraction (SVF). Adipose tissue is exceptionally abundant in ADSCs. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctors office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity. ADSCs are … Continue reading →

Durham, NC (PRWEB) April 23, 2014 Stress could activate "crosstalking" cell signals that decrease the bodys natural healing process after a wound occurs, according to a new study released today in STEM CELLS Translational Medicine. The finding helps explain how stress impairs healing and, conversely, could lead to a way to overcome chronic wounds resulting from serious burns and other skin injuries. Chronic wounds are a major global health problem, with annual costs in the United States alone of more than $23 billion, said Roslyn Isseroff, M.D., of the University of California Davis and the Northern California Health Care Systems Department of Veterans Affairs. She was a lead investigator in the study along with Mohan R. Dasu, Ph.D. The precise process that prevents their healing is unclear except for two constants: a prolonged inflammatory response and the bacterial colonization of the wound bed. These two interrelated factors are thought to contribute to the wounds chronic state. Previous studies had demonstrated an increase in epinephrine (adrenaline), as occurs during stress, produces an increase in the activity of TLR2 (Toll-like receptor 2), a protein that appears to stimulate the early inflammatory process needed to set the steps of healing in motion. Together … Continue reading →

Low back and neck pain; 6 months after stem cell therapy by Dr Harry Adelson Low back and neck pain; 6 months after stem cell therapy by Dr Harry Adelson http://www.docereclinics.com. By: Harry Adelson, N.D. … Continue reading →

The Orbsen Therapeutics team. The company has already worked on a number of FP7-funded cell therapy projects Orbsen Therapeutics, a spin-out from NUI Galways Regenerative Medicine Institute (Remedi) has announced plans to partner with the University of Birmingham in a 6 million project to fight liver disease. The stem cell research company, which was founded by Prof Frank Barry and Prof Tom OBrien in 2006, will collaborate with the university on an EU FP7-funded project known by as Merlin (MEsynchymal stem cells to Reduce Liver INflammation). The project, which is led by Prof Phil Newsome, will advance Orbsens proprietary cell therapy to a Phase 2a clinical trial. Orbsen, which was recently shortlisted for this years Irish Times InterTradeIreland Innovation awards, has developed and is patenting a unique method of isolating therapeutic stem cells from human tissue at class-leading levels of purity. The companys proprietary ORB1-MSC (Orbsen developed mesenchymal stromal cells) therapy is being developed for several diseases, including inflammatory disease of the lungs and liver, diabetes, cardiovascular disorders, joint disease, kidney injury, organ graft rejection and wound repair. The total research budget for the Merlin project is close to 6 million of which 1 million will go directly to Orbsen … Continue reading →

The Orbsen Therapeutics team. The company has already worked on a number of FP7-funded cell therapy projects Orbsen Therapeutics, a spin-out from NUI Galways Regenerative Medicine Institute (Remedi) has announced plans to partner with the University of Birmingham in a 6 million project to fight liver disease. The stem cell research company, which was founded by Prof Frank Barry and Prof Tom OBrien in 2006, will collaborate with the university on an EU FP7-funded project known by as Merlin (MEsynchymal stem cells to Reduce Liver INflammation). The project, which is led by Prof Phil Newsome, will advance Orbsens proprietary cell therapy to a Phase 2a clinical trial. Orbsen, which was recently shortlisted for this years Irish Times InterTradeIreland Innovation awards, has developed and is patenting a unique method of isolating therapeutic stem cells from human tissue at class-leading levels of purity. The companys proprietary ORB1-MSC (Orbsen developed mesenchymal stromal cells) therapy is being developed for several diseases, including inflammatory disease of the lungs and liver, diabetes, cardiovascular disorders, joint disease, kidney injury, organ graft rejection and wound repair. The total research budget for the Merlin project is close to 6 million of which 1 million will go directly to Orbsen … Continue reading →